Developer docs
API playgroundTry for free, no card

Search company profiles

Osteogenics

Full company profile

uuid000mjo2

Namestring
Osteogenics
Legal namestring
Osteogenics Biomedical, Inc.
Websiteurl
osteogenics.com
Company typeenum
Private
Founded yearint
1996
Descriptiontext

Osteogenics Biomedical, Inc. is a privately held dental regenerative medicine company founded in 1996 and headquartered in Lubbock, Texas. It manufactures and distributes a comprehensive portfolio of products used by oral surgeons, periodontists, prosthodontists, and general dentists in implant and reconstructive dental procedures. The core catalog spans non-resorbable and resorbable barrier membranes (Cytoplast™ dPTFE and titanium-reinforced membranes with proprietary Regentex™ surface texturing), bone graft substitutes (allograft, porcine xenograft under the Zcore™ brand with 88-95% void space, and synthetic alloplasts), soft tissue grafts (Cytoplast MicroDerm™ acellular dermal matrix with micro-cuts), sutures (PTFE non-absorbable and absorbable), fixation and tenting systems (Pro-fix™), bone harvesting instruments, ridge preservation kits, and osseodensification instruments distributed in partnership with Versah.

The company's commercial model is sales-led and direct-to-practitioner: US customers purchase through an account-gated eCommerce storefront with same-day shipping, while international customers (120+ countries) are served via a global distributor network. Revenue is generated almost entirely from one-time product sales, supplemented by a high-margin clinical education business — Osteogenics co-hosts recurring multi-day, multi-CE-credit courses with KOL-led partners (Pikos Institute, gIDE, Urban Regeneration Institute) at price points ranging from $695 to $19,996 per attendee. Marketing is anchored on clinical literature, peer-reviewed studies, surgical video content, and tradeshow participation rather than consumer advertising. The company operates within the Envista family of dental companies and is led by founder and co-owner Chad Bartee.

Short descriptiontext

Osteogenics Biomedical manufactures dental regenerative products — barrier membranes, bone graft substitutes, soft tissue grafts, sutures, and fixation systems — sold directly to dental professionals in the US and through distributors in 120+ countries, supplemented by KOL-led clinical education courses.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersLubbock, United States
HQ citystring
Lubbock
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
dental regenerative products, bone graft substitutes, barrier membranes, dental surgical instruments, tissue regeneration devices
Product category
Dental Medical Devices
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Medical Device and Biomaterial Sales
TypeOne Time License
Description

Osteogenics generates revenue through the sale of dental regenerative products including barrier membranes (dPTFE, collagen), bone graft substitutes (allograft, xenograft, alloplast), soft tissue grafts, sutures, fixation systems, and surgical instruments. Products are sold directly to dental professionals via eCommerce (US customers) and through international distributor network.

osteogenics.com
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Pricing details10 tiers
1Standard product pricing with volume-based bulk discounts
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Buy 5 Boxes Get 1 Free (membranes, bone graft materials, sutures); Buy 12 Boxes Get 3 Free; Buy 30 Boxes Get 10 Free. Free 2nd Day Shipping on online orders over $350.

osteogenics.com
2Versah Osseodensification Training Course - December 11, 2026
ModelOtherBilling cadencePay-as-you-go
Notes

$1,399 per attendee for 7 CE Credits

osteogenics.com
3Pikos Guided Full Arch Immediate Implant Reconstruction - December 3-5, 2026
ModelOtherBilling cadencePay-as-you-go
Notes

$5,795 per attendee for 24 CE Credits

osteogenics.com
4Pikos Mastering Implant Dentistry Fundamentals - Module 2 - November 5-7, 2026
ModelOtherBilling cadencePay-as-you-go
Notes

$19,996 per attendee for 108 CE Credits

osteogenics.com
5gIDE Advanced Tissue Regeneration - October 13-16, 2026
ModelOtherBilling cadencePay-as-you-go
Notes

$4,795 per attendee for 32 CE Credits

osteogenics.com
6Pikos Contemporary Soft Tissue Grafting - October 8-10, 2026
ModelOtherBilling cadencePay-as-you-go
Notes

$5,795 per attendee for 23 CE Credits

osteogenics.com
7Management of Hard and Soft Tissue Course - September 19, 2026
ModelOtherBilling cadencePay-as-you-go
Notes

$695 per attendee

osteogenics.com
8gIDE Master Clinician Session 4 Symposium - September 14-18, 2026
ModelOtherBilling cadencePay-as-you-go
Notes

$19,900 per attendee for 300 CE Credits

osteogenics.com
9Versah Osseodensification and Advanced Course - September 11-12, 2026
ModelOtherBilling cadencePay-as-you-go
Notes

$1,399 - $3,298 per attendee for 7-14 CE Credits

osteogenics.com
10Osteogenics and Nobel Biocare 2026 Advanced Bone Grafting Symposium - May 1-2, 2026
ModelOtherBilling cadencePay-as-you-go
Notes

$995 per attendee for 13.5 CE Credits; $500 for Assistants & Office Personnel; Optional workshops $695-$995

osteogenics.com
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 5 records shown
1Cytoplast
Description

Product line including TXT-200 Non-Resorbable High-Density PTFE Membranes, Ti-250 and Ti-150 Titanium-Reinforced PTFE Membranes, and Non-Absorbable PTFE Sutures

osteogenics.com
+4 more records
Core offering1 text field

No information available in the provided input.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 2 values shown
  • Product availability rate of 99% to minimize back-orders
+1 more record
Product overview1 text field

Osteogenics Biomedical is a dental regenerative medicine company offering a comprehensive portfolio of products for oral surgery and implant dentistry. The product line centers on barrier membranes (Cytoplast™ dPTFE and titanium-reinforced membranes), bone graft substitutes (allograft, xenograft from porcine sources including Zcore™ products, and synthetic alloplast materials), and soft tissue augmentation materials (including Cytoplast MicroDerm™ acellular dermal matrix). Additional offerings include sutures (absorbable and non-absorbable PTFE), fixation and tenting systems, bone harvesting instruments, ridge preservation kits, surgical blades, textbooks, and osseodensification products through Versah partnership. The portfolio is organized around surgical procedures including ridge preservation, horizontal and vertical ridge augmentation, sinus elevation, soft tissue augmentation, and suturing.

Scale indicator2 records

Each record includes

Type, Value, Description, Source

Partnership6 partners
Strategic tierFlagshipTypeStrategic or Co-development PartnerAnnounced on2026-05-01
Description

Nobel Biocare partnered with Osteogenics to present the 2026 Advanced Bone Grafting Symposium in Scottsdale, AZ. This is Osteogenics' flagship educational event featuring multiple KOL speakers covering topics like vertical ridge augmentation, GBR, sinus grafting, and osseodensification. Nobel Biocare is a leading dental implant company.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Versah is a key educational and distribution partner for osseodensification products. Osteogenics hosts and promotes Versah Osseodensification Training Courses and offers Versah products through their platform. Courses cover osseodensification techniques for sub-crestal sinus lifts, ridge expansion, and immediate implant placement.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Pikos Institute is a premier dental implant education partner. Osteogenics hosts Pikos courses including Mastering Implant Dentistry Fundamentals, Sinus Grafting, Soft Tissue Grafting, and Guided Full Arch Reconstruction. Dr. Michael Pikos is featured as a key opinion leader.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

gIDE (Global Institute for Dental Education) is a partner for advanced implant dentistry training. Osteogenics sponsors gIDE Master Clinician programs and Advanced Tissue Regeneration courses taught by Dr. Sascha Jovanovic.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Led by Dr. Istvan Urban, the Urban Regeneration Institute offers advanced bone and soft tissue regeneration courses. Osteogenics hosts these courses including the 3-Day Advanced Bone & Soft Tissue Course in Budapest, Hungary.

Strategic tierCoreTypeOthers
Description

Osteogenics is part of the Envista family of companies. The CCP Declaration page references Envistaco.com compliance and transparency. Contact person Abby Adams is listed as an Envista employee handling symposium inquiries.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Swiss-headquartered leader in dental bone regeneration (Bio-Oss xenograft) and barrier membranes (Bio-Gide). Directly comparable as a regenerative-only dental specialist with global distribution serving periodontists and oral surgeons.

2Dentsply Sirona
TypeBroad incumbent
Description

Largest pure-play dental equipment and consumables company with an implant and regenerative materials portfolio (Astra Tech, Ankylos). Broad incumbent that overlaps with Osteogenics' regenerative offerings as part of a much wider portfolio.

TypeBroad incumbent
Description

Global dental implant leader that has expanded into regenerative materials (botiss biomaterials acquired in 2021). Comparable customer base (implantologists, periodontists) and overlapping product categories in membranes and bone grafts.

TypeBroad incumbent
Description

Spun off from Zimmer Biomet, ZimVie sells dental implants plus regenerative products including bone grafts and membranes. Overlaps with Osteogenics in regenerative biomaterials and serves the same surgical specialists.

TypeBroad incumbent
Description

Premium dental implant company and Osteogenics' flagship educational symposium partner (2026 Advanced Bone Grafting Symposium). Overlaps in regenerative materials and serves an identical clinician base.

6Botiss Biomaterials
TypeDirect peer
Description

German regenerative specialist offering bone grafts (cerabone, maxgraft), soft tissue grafts (mucoderm), and barrier membranes. Closely comparable product portfolio targeting periodontists and oral surgeons across Europe.

TypeDirect peer
Description

Non-profit allograft tissue organization offering dental bone grafts and soft tissue grafts (DermACELL). Directly comparable in the allograft/acellular dermal matrix space that includes Cytoplast MicroDerm.

8RTI Surgical
TypeDirect peer
Description

Tissue-based implant manufacturer serving dental and other surgical specialties with allograft and xenograft bone graft substitutes. Overlaps with Osteogenics' bone graft franchise.

TypeDirect peer
Description

Manufacturer of synthetic bone graft substitutes (calcium phosphosilicate) for dental and orthopedic applications. Currently featured as a promotional partner on Osteogenics' homepage, indicating close category overlap.

TypeDirect peer
Description

Dental surgical product distributor and manufacturer specializing in bone grafting materials, membranes, sutures, and instrumentation for oral surgeons and periodontists — near-identical product breadth to Osteogenics.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers7 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
Compliance2 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Osteogenics

Dental Medical Devicesosteogenics.com

Osteogenics Biomedical manufactures dental regenerative products — barrier membranes, bone graft substitutes, soft tissue grafts, sutures, and fixation systems — sold directly to dental professionals in the US and through distributors in 120+ countries, supplemented by KOL-led clinical education courses.

What Osteogenics does

Osteogenics Biomedical, Inc. is a privately held dental regenerative medicine company founded in 1996 and headquartered in Lubbock, Texas. It manufactures and distributes a comprehensive portfolio of products used by oral surgeons, periodontists, prosthodontists, and general dentists in implant and reconstructive dental procedures. The core catalog spans non-resorbable and resorbable barrier membranes (Cytoplast™ dPTFE and titanium-reinforced membranes with proprietary Regentex™ surface texturing), bone graft substitutes (allograft, porcine xenograft under the Zcore™ brand with 88-95% void space, and synthetic alloplasts), soft tissue grafts (Cytoplast MicroDerm™ acellular dermal matrix with micro-cuts), sutures (PTFE non-absorbable and absorbable), fixation and tenting systems (Pro-fix™), bone harvesting instruments, ridge preservation kits, and osseodensification instruments distributed in partnership with Versah.

The company's commercial model is sales-led and direct-to-practitioner: US customers purchase through an account-gated eCommerce storefront with same-day shipping, while international customers (120+ countries) are served via a global distributor network. Revenue is generated almost entirely from one-time product sales, supplemented by a high-margin clinical education business — Osteogenics co-hosts recurring multi-day, multi-CE-credit courses with KOL-led partners (Pikos Institute, gIDE, Urban Regeneration Institute) at price points ranging from $695 to $19,996 per attendee. Marketing is anchored on clinical literature, peer-reviewed studies, surgical video content, and tradeshow participation rather than consumer advertising. The company operates within the Envista family of dental companies and is led by founder and co-owner Chad Bartee.

Osteogenics firmographics

Firmographics
Name
Osteogenics
Legal name
Osteogenics Biomedical, Inc.
Website
https://osteogenics.com
Company type
Private
Founded year
1996
Operating status
Operating
Headcount range
51–100 employees
Short description
Osteogenics Biomedical manufactures dental regenerative products — barrier membranes, bone graft substitutes, soft tissue grafts, sutures, and fixation systems — sold directly to dental professionals in the US and through distributors in 120+ countries, supplemented by KOL-led clinical education courses.
Ownership category
akta.pro rank

Where Osteogenics is headquartered

Location

Headquarters

HQ city
Lubbock
HQ country
United States
HQ region
North America

Offices1 record

Markets served

Osteogenics business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing

Revenue model

  1. Medical Device and Biomaterial Sales: Osteogenics generates revenue through the sale of dental regenerative products including barrier membranes (dPTFE, collagen), bone graft substitutes (allograft, xenograft, alloplast), soft tissue grafts, sutures, fixation systems, and surgical instruments. Products are sold directly to dental professionals via eCommerce (US customers) and through international distributor network.

Pricing tiers

ModelBillingPrice
Unit PricingPay-as-you-goStandard product pricing with volume-based bulk discounts
OtherPay-as-you-goVersah Osseodensification Training Course - December 11, 2026
OtherPay-as-you-goPikos Guided Full Arch Immediate Implant Reconstruction - December 3-5, 2026
OtherPay-as-you-goPikos Mastering Implant Dentistry Fundamentals - Module 2 - November 5-7, 2026
OtherPay-as-you-gogIDE Advanced Tissue Regeneration - October 13-16, 2026
OtherPay-as-you-goPikos Contemporary Soft Tissue Grafting - October 8-10, 2026
OtherPay-as-you-goManagement of Hard and Soft Tissue Course - September 19, 2026
OtherPay-as-you-gogIDE Master Clinician Session 4 Symposium - September 14-18, 2026
OtherPay-as-you-goVersah Osseodensification and Advanced Course - September 11-12, 2026
OtherPay-as-you-goOsteogenics and Nobel Biocare 2026 Advanced Bone Grafting Symposium - May 1-2, 2026

Go-to-market motion1 record

Distribution channels3 records

Marketing channels6 records

Osteogenics product offering

Product offering

Core offering

No information available in the provided input.

Product overview

Osteogenics Biomedical is a dental regenerative medicine company offering a comprehensive portfolio of products for oral surgery and implant dentistry. The product line centers on barrier membranes (Cytoplast™ dPTFE and titanium-reinforced membranes), bone graft substitutes (allograft, xenograft from porcine sources including Zcore™ products, and synthetic alloplast materials), and soft tissue augmentation materials (including Cytoplast MicroDerm™ acellular dermal matrix). Additional offerings include sutures (absorbable and non-absorbable PTFE), fixation and tenting systems, bone harvesting instruments, ridge preservation kits, surgical blades, textbooks, and osseodensification products through Versah partnership. The portfolio is organized around surgical procedures including ridge preservation, horizontal and vertical ridge augmentation, sinus elevation, soft tissue augmentation, and suturing.

Differentiator

Problem solved

Functional benefit

Brands

  • Cytoplast: Product line including TXT-200 Non-Resorbable High-Density PTFE Membranes, Ti-250 and Ti-150 Titanium-Reinforced PTFE Membranes, and Non-Absorbable PTFE Sutures
  • Zcore
  • Cytoplast MicroDerm
  • Pro-fix
  • enCore

Quantifiable outcome

  • Product availability rate of 99% to minimize back-orders
  • +1 more outcomes

Companies that use Osteogenics

Customer profile

Named customers7 records

Segments3 records

Osteogenics technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature4 records

Osteogenics partnerships and signals

Strategic signal

Partnerships

Six partnerships are on record, tiered flagship and core.

  • Nobel BiocareflagshipStrategic or Co-development Partner · 1 May 2026Nobel Biocare partnered with Osteogenics to present the 2026 Advanced Bone Grafting Symposium in Scottsdale, AZ. This is Osteogenics' flagship educational event featuring multiple KOL speakers covering topics like vertical ridge augmentation, GBR, sinus grafting, and osseodensification. Nobel Biocare is a leading dental implant company.
  • VersahcoreStrategic or Co-development PartnerVersah is a key educational and distribution partner for osseodensification products. Osteogenics hosts and promotes Versah Osseodensification Training Courses and offers Versah products through their platform. Courses cover osseodensification techniques for sub-crestal sinus lifts, ridge expansion, and immediate implant placement.
  • Pikos InstitutecoreStrategic or Co-development PartnerPikos Institute is a premier dental implant education partner. Osteogenics hosts Pikos courses including Mastering Implant Dentistry Fundamentals, Sinus Grafting, Soft Tissue Grafting, and Guided Full Arch Reconstruction. Dr. Michael Pikos is featured as a key opinion leader.
  • gIDE InstitutecoreStrategic or Co-development PartnergIDE (Global Institute for Dental Education) is a partner for advanced implant dentistry training. Osteogenics sponsors gIDE Master Clinician programs and Advanced Tissue Regeneration courses taught by Dr. Sascha Jovanovic.
  • Urban Regeneration InstitutecoreStrategic or Co-development PartnerLed by Dr. Istvan Urban, the Urban Regeneration Institute offers advanced bone and soft tissue regeneration courses. Osteogenics hosts these courses including the 3-Day Advanced Bone & Soft Tissue Course in Budapest, Hungary.
  • Envista (Parent Company)coreOthersOsteogenics is part of the Envista family of companies. The CCP Declaration page references Envistaco.com compliance and transparency. Contact person Abby Adams is listed as an Envista employee handling symposium inquiries.

Scale indicators2 records

Recent moves6 records

Expansion highlights5 records

Osteogenics competitors and assessment

Company assessment

Direct peers

  • Geistlich Pharma: Swiss-headquartered leader in dental bone regeneration (Bio-Oss xenograft) and barrier membranes (Bio-Gide). Directly comparable as a regenerative-only dental specialist with global distribution serving periodontists and oral surgeons.
  • Botiss Biomaterials: German regenerative specialist offering bone grafts (cerabone, maxgraft), soft tissue grafts (mucoderm), and barrier membranes. Closely comparable product portfolio targeting periodontists and oral surgeons across Europe.
  • LifeNet Health: Non-profit allograft tissue organization offering dental bone grafts and soft tissue grafts (DermACELL). Directly comparable in the allograft/acellular dermal matrix space that includes Cytoplast MicroDerm.
  • RTI Surgical: Tissue-based implant manufacturer serving dental and other surgical specialties with allograft and xenograft bone graft substitutes. Overlaps with Osteogenics' bone graft franchise.
  • NovaBone Products: Manufacturer of synthetic bone graft substitutes (calcium phosphosilicate) for dental and orthopedic applications. Currently featured as a promotional partner on Osteogenics' homepage, indicating close category overlap.
  • Salvin Dental Specialties: Dental surgical product distributor and manufacturer specializing in bone grafting materials, membranes, sutures, and instrumentation for oral surgeons and periodontists — near-identical product breadth to Osteogenics.

Broad incumbents

  • Dentsply Sirona: Largest pure-play dental equipment and consumables company with an implant and regenerative materials portfolio (Astra Tech, Ankylos). Broad incumbent that overlaps with Osteogenics' regenerative offerings as part of a much wider portfolio.
  • Straumann Group: Global dental implant leader that has expanded into regenerative materials (botiss biomaterials acquired in 2021). Comparable customer base (implantologists, periodontists) and overlapping product categories in membranes and bone grafts.
  • ZimVie (Zimmer Biomet Dental): Spun off from Zimmer Biomet, ZimVie sells dental implants plus regenerative products including bone grafts and membranes. Overlaps with Osteogenics in regenerative biomaterials and serves the same surgical specialists.
  • Nobel Biocare: Premium dental implant company and Osteogenics' flagship educational symposium partner (2026 Advanced Bone Grafting Symposium). Overlaps in regenerative materials and serves an identical clinician base.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

Osteogenics social profiles

Digital presence

Osteogenics compliance and trust

Trust signal

Compliance2 records

Osteogenics financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Osteogenics leadership team

Management profile

Number of profiles

Osteogenics funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Osteogenics M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Osteogenics

What does Osteogenics do?

No information available in the provided input.

Is Osteogenics a public or private company?

Osteogenics is a private company. It is classified as unknown and is currently operating.

When was Osteogenics founded?

Osteogenics was founded in 1996. It employs 51 to 100 people.

Where is Osteogenics based?

Osteogenics is headquartered in Lubbock, United States, in the North America region.

How does Osteogenics make money?

One revenue line is on record: medical Device and Biomaterial Sales.

Who are Osteogenics's main competitors?

Direct peers on record are Geistlich Pharma, Botiss Biomaterials, LifeNet Health, RTI Surgical, NovaBone Products and Salvin Dental Specialties. Broad incumbents are Dentsply Sirona, Straumann Group, ZimVie (Zimmer Biomet Dental) and Nobel Biocare.

Does Osteogenics have an API?

No public API is recorded for Osteogenics.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
DentaleconomicsDental Launch Radar: Mid-March 2026Three new dental technology products were launched in mid-March 2026, including OsteoGen's Bioactive Crystal Technology for bone grafting and Planet DDS's AI agents for practice management. SciCan also introduced the HYDRIM 112W G4+, an automated instrument washer featuring smart monitoring capabilities to enhance infection control and efficiency.PR NewswireEnvista Reports Second Quarter 2022 EarningsEnvista Holdings Corporation reported second-quarter 2022 earnings with sales increasing 1.3% to $645.8 million and adjusted net income of $0.48 per diluted share, while completing the acquisitions of Carestream Dental's Intraoral Scanner business and Osteogenics' Regenerative Solutions business. The company updated its full-year guidance, citing persistent inflationary pressures, supply chain disruptions, and geopolitical uncertainties as factors creating downside risk for demand in the second half of 2022.PR NewswireENVISTA TO ACQUIRE OSTEOGENICS BIOMEDICAL BUSINESSEnvista Holdings entered a definitive agreement to acquire Osteogenics Biomedical, Allotech, and OBI Biologics, expected to close in Q3. The deal is not subject to financing or shareholder vote. Envista aims to expand its regenerative solutions portfolio for dental clinicians.PR NewswireSouth Korea Dental Bone Graft Substitutes and Other Biomaterials Markets, 2024 - Overview, Competitive Analysis, Market Trends & Market DevelopmentsResearch and Markets announced the release of a market research report covering South Korea's dental bone graft substitutes and biomaterials market from 2018 to 2024. The report analyzes market trends, competitive dynamics, and forecasts across segments including allografts, xenografts, synthetic grafts, dental growth factors, and barrier membranes. Geistlich, Genoss, Hans Biomed, Oscotec, Zimmer Biomet, NIBEC, Osteogenics, LifeNet Health, Biomatlante, and ACE Surgical are listed as companies covered in the report.